Intriguingly, in vitro analysis revealed that activation of the GPR17 agonist favored the selective survival of Oligo 2 cells and altered the proliferative ability of glioma cells by decreasing the number of neurospheres [27]. The gene discussed is GPR17; the disease is glioma.